ANI Pharmaceuticals ANIP Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from ANI Pharmaceuticals’s reported figures.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's total debt?
- ANI Pharmaceuticals (ANIP) reported total debt of $305.29M in Q1 2026.
- How has ANI Pharmaceuticals's total debt changed year-over-year?
- ANI Pharmaceuticals's total debt decreased by 3.5% year-over-year, from $316.49M to $305.29M.
- What is the long-term trend for ANI Pharmaceuticals's total debt?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's total debt has grown at a 11.5% compound annual growth rate (CAGR), from $185.99M to $320.36M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.